Carrie D'Andrea
Chief Tech/Sci/R&D Officer at ACASTI PHARMA INC.
Net worth: - $ as of 30/05/2024
Profile
Ms. Carrie D'Andrea is a Vice President-Clinical Operations at Acasti Pharma, Inc. Ms. D'Andrea was previously employed as a Vice President-Clinical Operations by EryDel SpA and a Vice President-Clinical Operations by Edge Therapeutics, Inc. She received her graduate degree from Temple University (Pennsylvania).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/05/2024 | 0 ( -.--% ) | - $ | 30/05/2024 |
Carrie D'Andrea active positions
| Companies | Position | Start |
|---|---|---|
| ACASTI PHARMA INC. | Chief Tech/Sci/R&D Officer | 07/05/2023 |
Former positions of Carrie D'Andrea
| Companies | Position | End |
|---|---|---|
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 31/03/2021 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Chief Tech/Sci/R&D Officer | 28/02/2019 |
Training of Carrie D'Andrea
| Temple University (Pennsylvania) | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| Private companies | 2 |
|---|---|
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Stock Market
- Insiders
- Carrie D'Andrea
